ANIX Anixa Biosciences Inc
Company Analysis
Latest News
🔴 Anixa Biosciences is trading 5.2% down today as oil prices and geopolitical tensions pressure equities
Anixa Biosciences is trading 5.2% down at $2.91 amid a weaker September 8, 2026 market. - The S&P 500 is down 0.59% and the Dow is down 1.18%, as rising oil...
🟢 Anixa Biosciences is trading 7.6% up in pre-market; no definitive catalyst identified
Anixa Biosciences is trading 7.6% up at $3.30, rebounding from the September 4, 2026 close of $3.07 after a prolonged decline. - No definitive...
Anixa Biosciences Inc Q3 2026 Earnings Preview: What Analysts Expect on September 09, 2026
For the third quarter of 2026, analysts expect Anixa Biosciences to report zero revenue and a net loss of $0.08 per share, with the current $3.07 share price...
🟢 Anixa Biosciences is trading 7.71% up in after-hours trading after updated lira-cel survival observations
Anixa Biosciences is trading 7.71% up at $3.31 in after-hours trading after updated survival observations from its ongoing Phase 1 lira-cel ovarian-cancer...
🟢 Anixa Biosciences is trading 10.81% up in pre-market after updated Phase 1 ovarian-cancer CAR-T survival observations
Anixa Biosciences is trading 10.81% up now at $3.38 after highlighting updated survival observations from its ongoing Phase 1 ovarian-cancer CAR-T trial. -...
Anixa's Cancer Patients Are Outliving Expectations — But Can a Micro-Cap Biotech Turn Survival Data Into Shareholder Value?
Shares of Anixa Biosciences surged 9.8% to $3.35 after the company highlighted updated survival data from its early-stage ovarian cancer trial — a notable...
🟢 Anixa Biosciences is trading 9.84% up in after-hours trading after positive lira-cel ovarian-cancer CAR-T survival update
Anixa Biosciences is trading 9.84% up at $3.35 after reporting updated positive survival observations from its ongoing Phase 1 lira-cel ovarian-cancer CAR-T...
🟢 Anixa Biosciences is trading 5% up in pre-market
Anixa Biosciences is trading 5.11% up at $3.29 versus the September 2, 2026 close of $3.13; no verified catalyst has been identified. - The latest company...
🟢 Anixa Biosciences is trading 6.07% up in after-hours trading; no verified catalyst identified
Anixa Biosciences is trading 6.07% up at $3.32 after closing at $3.13 on September 2, 2026, with the catalyst unclear. - Searches found no verified...
🟢 Anixa Biosciences is trading 10.37% up in pre-market on September 2, 2026; no clear catalyst identified
Anixa Biosciences is trading 10.37% up in pre-market at $3.62, with no clear company-specific catalyst identified. - The stock closed at $3.28 on September 1,...
🟢 Anixa Biosciences is trading 7.32% up in after-hours trading — no clear company-specific catalyst identified
Anixa Biosciences is trading 7.32% up at $3.52 after closing at $3.28 on September 1, 2026, with no clear company-specific announcement, earnings release, or...
🟢 Anixa Biosciences is trading 8% up in pre-market despite no clear company-specific news
Anixa Biosciences is trading 8% higher at $3.62, up from the August 31 close of $3.35, with no clear company-specific announcement or overnight filing...
🟢 Anixa Biosciences is trading 6% up in after-hours trading with no confirmed company-specific catalyst
Anixa Biosciences is trading 6.03% up now at $3.69 in after-hours trading after closing at $3.48 on August 28, 2026, with no confirmed company-specific...
🟢 Anixa Biosciences is trading 6.1% up in pre-market — no confirmed company-specific catalyst
Anixa Biosciences is trading at $3.82 (+6.11%) after rising before the August 28, 2026 open, with no confirmed company-specific catalyst identified. - Recent...
🔴 Anixa Biosciences is trading 15.27% down in pre-market; cause unclear
Anixa Biosciences is trading 15.27% down now at $3.05 after falling sharply before the August 28, 2026 open; no confirmed company-specific announcement,...
🔴 Anixa Biosciences is trading 16.23% down in pre-market with no confirmed company-specific catalyst
Anixa Biosciences is trading 16.23% down at $3.02, with no confirmed company-specific announcement, filing, earnings release, or clinical update explaining the...
🔴 Anixa Biosciences is trading 7.17% down in after-hours trading with no confirmed company-specific catalyst
Anixa Biosciences is trading 7.17% down now at $3.35 in after-hours trading after closing at $3.60 on August 26, 2026, with no confirmed company-specific...
🟢 Anixa Biosciences is trading 5.37% up in pre-market as broader biotechnology strength lifts the sector
Anixa Biosciences is trading 5.37% up at $3.86 as broader biotechnology strength lifts the sector. - XBI gained 2.06% during the August 25 regular session,...
🟢 Anixa Biosciences is trading 5.4% up in after-hours trading as XBI gained 2.06%
Anixa Biosciences is trading 5.37% up now at $3.86, as broader biotechnology strength lifted the sector on August 25, 2026. - Biotechnology ETF XBI gained...
🟢 Anixa Biosciences is trading 6.35% up today amid broader biotechnology-sector strength
Anixa Biosciences is trading 6.35% up at $3.85, supported primarily by broader biotechnology-sector strength, with XBI up 2.06% during the regular session. -...